Resectable Esophageal Carcinoma: Preoperative Versus Postoperative Radiochemotherapy
It is generally accepted that chemotherapy and radiotherapy for esophageal carcinoma provide significant palliation, and multiple modality therapy has become the common trend during the past two decades [1, 2]. Surgery continues to be the cornerstone of treatment, and most protocols consist of surgical therapy combined with these adjuvant therapies. Preoperative radiation therapy was introduced in the 1960s and is still in use with promising results [3, 4]. However, there are several reports indicating that preoperative therapy neither improves the resectability nor the survival rate of patients who undergo resection [5, 6].
KeywordsHerpes Zoster Esophageal Carcinoma Preoperative Therapy Esophageal Disease Serum Glutamic Pyruvic Transaminase
Unable to display preview. Download preview PDF.
- 5.Eortc (1985) Preoperative radiotherapy for carcinoma of the esophagus: Results of a prospective multicenter study. In: DeMeester TR, Skinner DB (eds) Esophageal disorders: Pathophysiology and therapy. Raven, New York, pp 367–371Google Scholar